Project Details
| Status | Finished |
|---|---|
| Effective start/end date | 6/06/23 → 31/07/25 |
Keywords
- Clinical trial
- Haematology
- Multiple Myeloma
Clinical Trial Phase
- Phase I
An Open-Label, Multicenter, Phase Ib Trial Evaluating The Safety, Pharmacokinetics, And Activity Of The Combination Of Cevostamab And Elranatamab In Patients With Relapsed Or Refractory Multiple Myeloma
- Spencer, Andrew (Primary Chief Investigator (PCI))
- Malherbe, Maturos (Project Manager)
Project: Research